Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 3 1

Status

Unknown 21Completed 12Recruiting 10Not yet recruiting 5Terminated 3Active not recruiting 3

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 296Carcinoma, Hepatocellular 213Stomach Neoplasms 155Pancreatic Neoplasms 155Rectal Neoplasms 114Esophageal Neoplasms 84Colonic Neoplasms 78Esophageal Squamous Cell Carcinoma 52Cholangiocarcinoma 48Liver Neoplasms 47Biliary Tract Neoplasms 36Neoplasms 31Breast Neoplasms 31Neoplasm Metastasis 28Carcinoma, Non-Small-Cell Lung 27Gastrointestinal Neoplasms 26Lung Neoplasms 20Disease 18Prostatic Neoplasms 17Uterine Cervical Neoplasms 16Recurrence 16Ovarian Neoplasms 14Colorectal Neoplasms, Hereditary Nonpolyposis 13Endometrial Neoplasms 12Head and Neck Neoplasms 11Adenocarcinoma Of Esophagus 11Gallbladder Neoplasms 10Colonic Polyps 10Anus Neoplasms 10Melanoma 9

Interventions

tislelizumab 1Oxaliplatin 1Injections 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Locally Advanced Rectal Cancer × Gastrointestinal × Clear all
NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Fujian Cancer Hospital

Phase 2 Not yet recruiting
130 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT07453173 2026-03-05

ONCO-RET

Fundacion Arturo Lopez Perez

Phase NA Not yet recruiting
15 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT07074353 2025-07-25

CinClare-2

Zhejiang Cancer Hospital

Phase 3 Not yet recruiting
360 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT06760520 2025-01-08

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT05998122 2023-08-18

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

The First Hospital of Jilin University

Phase 2 Not yet recruiting
45 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡